Pfizer to deliver 100 million more doses of COVID-19 vaccine to U.S by July

BioNTech and Pfizer vaccine may be approved in the EU as early as December 21

With the new deal, the U.S. will receive 200 million doses of Pfizer’s vaccine
Pfizer said Wednesday it will deliver an additional 100 million doses of the COVID-19 vaccine to the United States by next July.
With this agreement, the total number of doses of Pfizer vaccine that the United States should receive would increase to 200 million, allowing 100 million people to be vaccinated.

Pfizer and its German partner BioNTech will deliver at least 70 million doses by June 30, and all 100 million doses will be delivered no later than July 31, the company said.
The U.S. government will pay $1.95 billion for the additional 100 million doses, bringing the total amount paid to Pfizer to nearly $4 billion.
The government had previously struck a deal with Pfizer to supply 100 million doses of the vaccine, which is now being distributed nationwide after the vaccine received regulatory approval earlier this month.
Scientists assessed the accuracy of COVID-19 prediction by Google

In addition to Pfizer’s vaccine, a vaccine from Moderna, based on similar technology, is registered in the United States.
The new agreement will help the United States step up its efforts to vaccinate its population amid rising rates of the coronavirus. Reuters estimates that more than one million new cases have been reported in the past six days.
The Centers for Disease Control and Prevention (CDC) reports that as of Monday, more than 600,000 Americans had already received their first doses of the vaccine.